
FDA Clears Prescription Digital Insomnia Therapeutic
Summary: The US Food and Drug Administration (FDA) has cleared SleepioRx, a digital therapeutic developed by Big Health for the treatment of chronic insomnia. SleepioRx employs cognitive behavioral therapy for insomnia (CBT-I) to address the cognitive and behavioral factors that sustain insomnia. The therapeutic has demonstrated efficacy in clinical trials, showing up to 76% of…
Read More